J&J Faces Risperdal Claims For 6th Time In Philadelphia
By Dan Packel ( December 2, 2016, 5:35 PM EST) -- The sixth trial in Philadelphia's Risperdal mass tort program began Friday with counsel for a Nebraska man telling a jury that the antipsychotic drug developed and manufactured by a Johnson & Johnson unit caused his client to develop breasts as an adolescent....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.